Medindia

X

Second Patient Dies in the First Phase of France's Artificial Heart Trial

by Dr. Trupti Shirole on  May 5, 2015 at 7:21 PM Clinical Trials News   - G J E 4
Artificial hearts are used as a temporary fix for patients with chronic heart problems. Biomedical firm Carmat has designed a self-contained unit, which is a mix of synthetic materials and animal tissue, and seeks to mimic the form and function of an actual human heart.
Second Patient Dies in the First Phase of France's Artificial Heart Trial
Second Patient Dies in the First Phase of France's Artificial Heart Trial
Advertisement

This artificial heart uses soft bio-materials intended to lessen the risk of blood clots and rejection by the immune system. It is powered by a belt of lithium batteries. Carmat was hoping to provide a longer-term solution to tens of thousands who suffer from heart disease and are unable to receive a transplant. However, the second person in France to have received this new-generation artificial heart has died eight months after receiving the transplant.

Advertisement
The 69-year-old man, who wished to remain anonymous, was terminally ill when he received this experimental heart that was seen as a long-term solution for patients with end-stage heart failure. Carmat said, "The patient was admitted to hospital on Friday with circulatory collapse." A medical team noted the heart was not functioning correctly and therefore a new device was transplanted, however the patient died on Saturday from post-operative complications.

Carmat's first trial of the device on a 76-year-old man ended March 2, 2015, with the patient's death after two and a half months. The French firm's trial was to involve four people. A third patient was confirmed to have received the artificial heart last week. The first phase of the trial will be considered to be successful if patients survive for a month after the transplant. Carmat will then carry out a second phase of clinical trials which will involve 20 heart patients.

Source: Medindia
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All